Square

Life Sciences — In Focus: FDA Diversity Action Plans: Deciphering the Guidance and its Consequences

What the research community has known for a long time recently became front-page news: Biomedical research has a diversity problem. Historically, clinical trials have enrolled primarily younger, white male participants. … Continue readingLife Sciences — In Focus: FDA Diversity Action Plans: Deciphering the Guidance and its Consequences

Life Sciences – In Focus: Leveraging Data and Trends for 2024 – Key Learnings

In the first installment of Vistatec’s Life Sciences – In Focus series, Amanda Murphy, Senior Director of Data Intelligence and Solutions at GlobalData, presented the biopharmaceutical industry’s outlook for 2024. The event yielded valuable insights into the trends and themes predicted for the upcoming year, focusing on the clinical trials landscape, including decentralized clinical trials and diversity. Read the key learnings here. … Continue readingLife Sciences – In Focus: Leveraging Data and Trends for 2024 – Key Learnings

Diversity in Clinical Trials: The Role of Language Services

Participant diversity is critical to achieving equitable representation in the clinical trial landscape. Sponsors must proactively plan outreach, enrollment, and retention strategies for diverse communities.
Such strategies should incorporate professional translation, language access, and culturally sensitive localization. Discover the importance of diversity in clinical trials and how LSPs can help.

Continue readingDiversity in Clinical Trials: The Role of Language Services